YFM leads $3 million round for Sirigen
Biomedical company Sirigen has closed a $3 million (£1.9 million) round led by YFM Equity Partners that will finance the bringing to market of its technology that tests the efficacy of drugs.
News
Biomedical company Sirigen has closed a $3 million (£1.9 million) round led by YFM Equity Partners that will finance the bringing to market of its technology that tests the efficacy of drugs.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software